The Peripheral Vascular Devices Market is entering a period of steady expansion as the rising prevalence of peripheral vascular diseases, an aging population, and continued medical device innovation increase demand for advanced vascular interventions. The market was valued at USD 9.5 billion in 2025 and is projected to reach USD 16.1 billion by 2033, growing at a 6.6% CAGR from 2026 to 2033.

Market at a Glance

• 2025 market size: USD 9.5 billion
• 2026 estimated size: USD 10.2 billion
• 2033 projected size: USD 16.1 billion
• CAGR: 6.6% from 2026 to 2033
• Largest region: North America, with 47.1% revenue share in 2025
• Fastest-growing region: Asia Pacific
• By type: Peripheral stents, with 22.2% share
• By application: Peripheral arterial disease (PAD), with 46.6% share
• By end use: Hospitals, with 40.5% share

Rising Peripheral Vascular Disease Burden Supports Market Expansion

The increasing prevalence of peripheral arterial disease (PAD) and venous diseases is one of the major factors supporting the peripheral vascular devices market. The global prevalence of PAD is projected to rise by approximately 220% by 2050, reaching around 360 million cases, with more than half of these cases expected in low- and middle-income countries.

The growing burden of metabolic disorders, particularly diabetes, is further contributing to PAD prevalence and progression. This expanding patient population is increasing the need for vascular diagnosis, intervention, and long-term disease management.

Download a free sample report or claim your copy of this full market intelligence report

Minimally Invasive Procedures Are Reshaping Vascular Treatment

A major shift from open vascular surgery toward minimally invasive catheter-based procedures is influencing the peripheral vascular devices market. Angioplasty, stenting, and atherectomy are increasingly preferred because of lower procedural risks, shorter hospital stays, and faster recovery.

Continuous clinical research is also supporting this transition. Clinical trials evaluating new vascular devices are helping validate existing technologies while creating opportunities for novel interventions designed to address unmet treatment needs.

Product Innovation Strengthens Competitive Opportunities

Technological advancement remains an important market characteristic. Manufacturers are developing drug-coated balloons, drug-eluting stents, bioresorbable scaffolds, and intravascular lithotripsy systems to improve treatment outcomes.

Recent product developments include advanced peripheral IVL systems designed to address vessel calcification and dissolvable scaffolds for below-the-knee PAD. These innovations are expanding treatment options and strengthening demand for next-generation peripheral vascular devices.

Peripheral Stents Lead the Product Landscape

The peripheral stents segment held the largest type share of 22.2% in 2025. These devices help reopen arteries narrowed or blocked by plaque and continue to benefit from technological advancements and regulatory approvals.

Meanwhile, the peripheral accessories segment is expected to register the fastest CAGR during the forecast period. Rising PAD prevalence and increasing minimally invasive procedures are driving demand for supportive devices, including advanced vascular closure technologies.

PAD Remains the Core Application Area

The peripheral arterial disease (PAD) segment accounted for the largest application share of 46.6% in 2025. Rising disease prevalence and increasing research activity are supporting demand for devices used in PAD diagnosis and treatment.

The aneurysms segment is expected to witness the fastest growth. Increasing risk with age and lifestyle-related factors such as smoking are expanding the high-risk population and supporting demand for screening and intervention.

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs.

Hospitals Continue to Dominate End Use

Hospitals represented the largest end-use segment, accounting for 40.5% of the market in 2025. Their specialized surgical units, advanced imaging capabilities, and trained medical professionals support complex vascular interventions.

At the same time, ambulatory surgical centers are expected to experience the fastest growth. The shift toward minimally invasive procedures, cost containment, and shorter hospital stays is increasing the relevance of these facilities for vascular interventions.

Regional Market Growth Reflects Expanding Vascular Care

North America dominated the peripheral vascular devices market with a 47.1% revenue share in 2025, supported by the rising incidence of PAD, an aging population, advanced healthcare infrastructure, and technological progress.

Asia Pacific is expected to register the fastest growth during the forecast period. Increasing vascular disease burden, healthcare infrastructure development, and growing adoption of advanced treatment solutions are strengthening market opportunities.

Europe is also expected to experience significant growth as an aging population increases demand for vascular interventions and healthcare systems continue adopting minimally invasive technologies. Latin America is supported by growing awareness of vascular diseases and advanced treatment options, while the Middle East and Africa are benefiting from expanding healthcare infrastructure and the rising burden of cardiovascular and peripheral artery diseases.

Competitive Landscape Encourages Innovation and Expansion

The peripheral vascular devices market has a medium degree of technological innovation, moderate merger and acquisition activity, and moderate regulatory impact. Companies are strengthening their positions through product launches, collaborations, acquisitions, and regional expansion.

The market continues to see developments in advanced stents, drug-coated technologies, bioresorbable platforms, and minimally invasive vascular procedures. Regulatory approvals are also influencing product development, particularly for higher-risk devices.

Key Companies

• Abbott
• Koninklijke Philips N.V.
• Edward Lifesciences Corporation
• Medtronic
• Teleflex Incorporated
• Boston Scientific Corporation

Explore the full list of profiled companies operating in this market with recent strategic initiatives

What Is Shaping the Peripheral Vascular Devices Market?

The market outlook is closely linked to the growing burden of PAD, increasing adoption of minimally invasive procedures, continued clinical research, and product innovation. As healthcare providers seek effective vascular interventions with improved recovery profiles, demand for advanced peripheral vascular devices is expected to continue increasing through 2033.

Explore our dedicated business services:

• U.S. Healthcare Facility Mapping & Intelligence Portal – Claims analytics (MS-DRG, service lines, ICD-10 outpatient, APC reimbursement, CPT-level) plus hospital-level financials (balance sheet, income statement, uncompensated care, financial health dashboards), covering 25,000+ healthcare facilities — including 7,000+ hospitals, independent pharmacies, freestanding EDs, concierge physicians, and ASCs.
• Brainshare Consulting – End-to-end business consulting services including Opportunity assessment, GTM support, Competitive intelligence, and Consumer Analytics.
• Custom Research – Get a market intelligence report tailored to your specific requirements and aligned with your business goals.
• Consumer Insights – Capture real, evolving consumer sentiment and behavior to help you make data driven strategies.
• Horizon Databooks – Access the world’s largest portal of Market Reports & Statistics
• Investment Insights – Make investment decisions with data driven insights, powered by domain and technology
• Signal (Pricing Intelligence) - Commodity price intelligence to drives strategic advantage.

About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.